Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
0.4900
-0.0090 (-1.80%)
May 2, 2025, 4:00 PM EDT - Market closed
Aptevo Therapeutics Market Cap
Aptevo Therapeutics has a market cap or net worth of $1.61 million as of May 2, 2025. Its market cap has increased by 303.30% in one year.
Market Cap
1.61M
Enterprise Value
-1.70M
1-Year Change
303.30%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since July 20, 2016, Aptevo Therapeutics's market cap has decreased from $161.90M to $1.61M, a decrease of -99.00%. That is a compound annual growth rate of -40.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 700.00K | -68.18% |
| Dec 31, 2024 | 2.20M | -31.25% |
| Dec 29, 2023 | 3.20M | -72.88% |
| Dec 30, 2022 | 11.80M | -69.43% |
| Dec 31, 2021 | 38.60M | -74.59% |
| Dec 31, 2020 | 151.90M | 413.18% |
| Dec 31, 2019 | 29.60M | 2.78% |
| Dec 31, 2018 | 28.80M | -68.28% |
| Dec 29, 2017 | 90.80M | 83.81% |
| Dec 30, 2016 | 49.40M | -69.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.19B |
| Johnson & Johnson | 372.32B |
| UnitedHealth Group | 365.68B |
| AbbVie | 344.28B |
| Novo Nordisk | 293.18B |
| Abbott Laboratories | 228.27B |
| Novartis AG | 223.05B |
| AstraZeneca | 221.80B |